Role of human T-cell leukemia virus type I Tax in expression of the human telomerase reverse transcriptase (hTERT) gene in human T-cells

Cancer Science

Volumn 99, Issue 6, 2008, Pages 1155-1163

  Hara, Toshifumi ^a   Matsumura Arioka, Yuuki ^a   Ohtani, Kiyoshi ^a   Nakamura, Masataka ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D2; CYCLIN DEPENDENT KINASE 4; PROTEIN P130; SHORT HAIRPIN RNA; TAX PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CELL CULTURE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; LEUKOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPRESSOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; UPREGULATION; VIRUS CARCINOGENESIS;

CELL CYCLE PROTEINS; CELL LINE, TRANSFORMED; CELLS, CULTURED; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; JURKAT CELLS; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; S PHASE; T-LYMPHOCYTES; TELOMERASE; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC;

EID: 43549111438     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00798.x     Document Type: Article

References (51)

1. Hinuma Y, Nagata K, Hanaoka M et al. Adult T-cell leukemia -antigen in an ATL cell-line and detection of antibodies to the antigen in human-sera. Proc Natl Acad Sci USA 1981; 78: 6476-80.
2. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell-lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982; 79: 2031-5.
3. Grassmann R, Dengler C, Mullerfleckenstein I et al. Transformation to continuous growth of primary human lymphocytes-T by human T-cell leukemia-virus type-I, x-region genes transduced by a herpesvirus-saimiri vector. Proc Natl Acad Sci USA 1989; 86: 3351-5.
4. Akagi T, Ono H, Shimotohno K. Characterization of T-cells immortalized by Tax1 of human T-cell leukemia-virus type-1. Blood 1995; 86: 4243-9.
5. Nerenberg M, Hinrichs SH, Reynolds RK, Khoury G, Jay G. The tat gene of human T-lymphotropic virus type-1 induces mesenchymal tumors in transgenic mice. Science 1987; 237: 1324-9.
6. Grossman WJ, Kimata JT, Wong FH, Zutter M, Ley TJ, Ratner L. Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia-virus type-I. Proc Natl Acad Sci USA 1995; 92: 1057-61.
7. Hasegawa H, Sawa H, Lewis MJ et al. Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat Med 2006; 12: 466-72.
8. Felber BK, Paskalis H, Kleinmanewing C, Wongstaal F, Pavlakis GN. The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. Science 1985; 229: 675-9.
9. Sodroski J, Rosen C, Goh WC, Haseltine W. A transcriptional activator protein encoded by the x-lor region of the human T-cell leukemia-virus. Science 1985; 228: 1430-4.
10. Yoshida M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol 2001; 19: 475-96.
11. Jeang KT, Boros I, Brady J, Radonovich M, Khoury G. Characterization of cellular factors that interact with the human T-cell leukemia-virus type-I p40X-responsive 21-base-pair sequence. J Virol 1988; 62: 4499-509.
12. Leung K, Nabel GJ. HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kB-like factor. Nature 1988; 333: 776-8.
13. Zhao LJ, Giam CZ. Human T-cell lymphotropic virus type-I (HTLV-I) transcriptional activator, tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein protein interaction. Proc Natl Acad Sci USA 1992; 89: 7070-4.
14. Fujii M, Tsuchiya H, Chuhjo T, Akizawa T, Seiki M. Interaction of HTLV-1 Tax1 with p67 (SRF) causes the aberrant induction of cellular immediate early genes through carg boxes. Genes Dev 1992; 6: 2066-76.
15. Jeang KT, Widen SG, Semmes OJ, Wilson SH. HTLV-I trans-activator protein, Tax, is a trans-repressor of the human b-polymerase gene. Science 1990; 247: 1082-4.
16. Hirai H, Suzuki T, Fujisawa J, Inoue J, Yoshida M. Tax protein of human T-cell leukemia-virus type-I binds to the ankyrin motifs of inhibitory factor kB and induces nuclear translocation of transcription factor NF-kB proteins for transcriptional activation. Proc Natl Acad Sci USA 1994; 91: 3584-8.
17. Suzuki T, Kitao S, Matsushime H, Yoshida M. HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16 (INK4A) and counteracts its inhibitory activity towards CDK4. Embo J 1996; 15: 1607-14.
18. Low KG, Dorner LF, Fernando DB, Grossman J, Jeang KT, Comb MJ. Human T-cell leukemia virus type 1 tax releases cell cycle arrest induced by p16 (INK4a). J Virol 1997; 71: 1956-62.
19. Pise-Masison CA, Choi KS, Radonovich M, Dittmer J, Kim SJ, Brady JN. Inhibition of p53 transactivation function by the human T-Cell lymphotropic virus type 1 Tax protein. J Virol 1998; 72: 1165-70.
20. Allsopp RC, Harley CB. Evidence for a critical telomere length in senescent human fibroblasts. Exp Cell Res 1995; 219: 130-6.
21. Harley CB, Futcher AB, Greider CW. Telomeres shorten during aging of human fibroblasts. Nature 1990; 345: 458-60.
22. Allsopp RC, Vaziri H, Patterson C et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992; 89: 10114-8.
23. Allsopp RC, Chang E, Kashefiaazam M et al. Telomere shortening is associated with cell-division in-vitro and in-vivo. Exp Cell Res 1995; 220: 194-200.
24. Nakamura TM, Morin GB, Chapman KB et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997; 277: 955-9.
25. Meyerson M, Counter CM, Eaton EN et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 1997; 90: 785-95.
26. Kim NW, Piatyszek MA, Prowse KR et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-5.
27. Broccoli D, Young JW, Delange T. Telomerase activity in normal and malignant hematopoietic-cells. Proc Natl Acad Sci USA 1995; 92: 9082-6.
28. Masutomi K, Yu EY, Khurts S et al. Telomerase maintains telomere structure in normal human cells. Cell 2003; 114: 241-53.
29. Hiyama K, Hirai Y, Kyoizumi S et al. Activation of telomerase in human-lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155: 3711-5.
30. Weng NP, Levine BL, June CH, Hodes RJ. Regulated expression of Telomerase activity in human T lymphocyte development and activation. J Exp Med 1996; 183: 2471-9.
31. Pawelec G, Rehbein A, Haehnel K, Merl A, Adibzadeh M. Human T-cell clones in long-term culture as a model of immunosenescence. Immunol Rev 1997; 160: 31-42.
32. Ohtani K, Iwanaga R, Arai M, Huang YP, Matsumura Y, Nakamura M. Cell type-specific E2F activation and cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I. J Biol Chem 2000; 275: 11154-63.
33. Matsumura-Arioka Y, Ohtani K, Hara T, Iwanaga R, Nakamura M. Identification of two distinct elements mediating activation of telomerase (hTERT) gene expression in association with cell growth in human T-cells. Int Immunol 2005; 17: 207-15.
34. Ohtani K, Nakamura M, Saito S et al. Identification of 2 distinct elements in the long terminal repeat of HTLV-I responsible for maximum gene-expression. Embo J 1987; 6: 389-95.
35. Quelle DE, Ashmun RA, Shurtleff SA et al. Overexpression of mouse d -type cyclins accelerates G (1) phase in rodent fibroblasts. Genes Dev 1993; 7: 1559-71.
36. Okada Y, Matsuura E, Tozuka Z et al. Upstream stimulatory factors stimulate transcription through E-box motifs in the PF4 gene in megakaryocytes. Blood 2004; 104: 2027-34.
37. Komori H, Enomoto M, Nakamura M, Iwanaga R, Ohtani K. Distinct E2F-mediated transcriptional program regulates p14 (ARF) gene expression. EMBO J 2005; 24: 3724-36.
38. Knudsen ES, Wang JYJ. Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol Cell Biol 1997; 17: 5771-83.
39. Ikeda M, Jakoi L, Nevins JR. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc Natl Acad Sci USA 1996; 93: 3215-20.
40. Gabet AS, Mortreux F, Charneau P et al. Inactivation of hTERT transcription by Tax. Oncogene 2003; 22: 3734-41.
41. Sinha-Datta U, Horikawa I, Michishita E et al. Transcriptional activation of hTERT through the NF-kB pathway in HTLV-1-transformed cells. Blood 2004; 104: 2523-31.
42. Tzukerman M, Shachaf C, Ravel Y et al. Identification of a novel transcription factor binding element involved in the regulation by differentiation of the human telomerase (hTERT) promoter. Mol Biol Cell 2000; 11: 4381-91.
43. Braunstein I, Cohen-Barak O, Shachaf C et al. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells. Cancer Res 2001; 61: 5529-36.
44. Yago M, Ohki R, Hatakeyama S, Fujita T, Ishikawa F. Variant forms of upstream stimulatory factors (USFs) control the promoter activity of hTERT, the human gene encoding the catalytic subunit of telomerase. FEBS Lett 2002; 520: 40-6.
45. Horikawa I, Cable PL, Mazur SJ, Appella E, Afshari CA, Barrett JC. Downstream E-box-mediated regulation of the human telomerase reverse transcriptase (hTERT) gene transcription: Evidence for an endogenous mechanism of transcriptional repression. Mol Biol Cell 2002; 13: 2585-97.
46. Huang YP, Ohtani K, Iwanaga R, Matsumura Y, Nakamura M. Direct trans-activation of the human cyclin D2 gene by the oncogene product Tax of human T-cell leukemia virus type I. Oncogene 2001; 20: 1094-102.
47. Sieburg M, Tripp A, Ma JW, Feuer G. Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 tax oncoproteins modulate cell cycle progression and apoptosis. J Virol 2004; 78: 10399-409.
48. Xu DW, Popov N, Hou M et al. Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc Natl Acad Sci USA 2001; 98: 3826-31.
49. Prowse KR, Greider CW. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci USA 1995; 92: 4818-22.
50. Horikawa L, Chiang YJ, Patterson T et al. Differential cis-regulation of human versus mouse TERT gene expression in vivo: Identification of a human-specific repressive element. Proc Natl Acad Sci USA 2005; 102: 18437-42.
51. Won JJ, Yim JB, Kim TK. Opposing regulatory roles of E2F in human telomerase reverse transcriptase (hTERT) gene expression in human tumor and normal somatic cells. FASEB J 2002; 16: 1943-5.